查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493372

美國血液透析機人造血管市場規模、佔有率、趨勢分析報告：按原料、地區、細分市場預測，2024-2030年

U.S. Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report By Raw Material (Polyester, Polytetrafluoroethylene), By Region (West, Midwest), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

美國血液透析機血管移植市場的成長與趨勢

Grand View Research最近的報告顯示，到2030年，美國血液透析機血管移植市場規模預計將達到6,850萬美元，2024年至2030年複合年成長率為4.5%。

市場的主要驅動力之一是末期腎病（ESRD）盛行率的上升。 ESRD 是一個重大的公共衛生問題，需要血液透析機作為維持生命治療的患者數量不斷增加。患者數量的增加推動了對血液透析機移植物的需求，以確保可靠地進行透析程序。

在血液透析機血管通路領域，微創手術有明顯的趨勢。微創技術可減少與傳統手術介入相關的患者不適、恢復時間和併發症。因此，醫療保健提供者擴大採用支持微創方法的血液透析機移植物，推動市場成長。

2023 年 4 月，BD 引入了採用 6F 和 8F 導管的 Aspirex 機械抽吸血栓切除系統，用於清除急性栓塞和血栓，以便血液透析機進入動靜脈移植物和自體動靜脈瘻管（Becton Dickinson & Company）。作為510(k) 使用。該設備將於 2022 年推出，具有三大支柱：透過導管有效清除通道中的凝塊的機械輸送、防止堵塞的連續凝塊浸漬以及增強的凝塊抽吸功能。

美國血液透析機人工血管市場報告亮點

  • 隨著人口老化以及糖尿病、高血壓等疾病的增加，需要血液透析機的人數不斷增加，推動了人造血管市場的發展。
  • 預計到 2023 年，聚四氟乙烯原料領域將以 45.5% 左右的佔有率主導市場，並在預測期內呈現最快的複合年成長率。這是由於它具有易於物料輸送、耐用性和抗感染性等優點。
  • 2023年6月，Merit Medical System Inc.以3,250萬美元收購了Bluegrass Vascular的導管系統，隨後又收購了AngioDynamics超過1億美元的資產。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國血液透析機人工血管市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國血液透析機人工血管市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國血液透析機人工血管市場：依原料估算及趨勢分析

  • 原物料市場佔有率（2023/2030）
  • 細分儀表板
  • 美國血液透析機人造血管市場前景：依原料分
  • 市場規模、預測與趨勢分析（2018-2030）

第5章美國血液透析機人工血管市場：區域估計與趨勢分析

  • 市場佔有率分析：按地區（2023/2030）
  • 美國血液透析機人工血管市場前景：按地區
  • 市場規模、預測與趨勢分析（2018-2030）
    • 西
    • 中西部
    • 東北
    • 西南
    • 東南

第6章 競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 主要企業熱圖分析（2023）
  • 公司簡介
    • Getinge
    • Medtronic
    • WL Gore &Associates
    • LeMaitre
    • CryoLife
    • Merit Medical Systems
    • CR Bard, Inc.
    • Vascudyne, Inc.
Product Code: GVR-4-68040-286-1

U.S. Hemodialysis Vascular Grafts Market Growth & Trends:

The U.S. hemodialysis vascular grafts market size is anticipated to reach USD 68.5 million by 2030, growing at a CAGR of 4.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the primary drivers of the market is the rising prevalence of end-stage renal disease (ESRD). ESRD is a significant public health concern, with a growing number of patients requiring hemodialysis as a life-sustaining treatment. This increasing patient population drives the demand for hemodialysis vascular grafts to create reliable access to dialysis procedures.

There is a noticeable trend towards minimally invasive procedures in the field of vascular access for hemodialysis. Minimally invasive techniques reduce patient discomfort, recovery time, and complications associated with traditional surgical interventions. As a result, healthcare providers are increasingly adopting hemodialysis vascular grafts that support minimally invasive approaches, driving market growth.

In April 2023, the Aspirex mechanical suction thrombectomy system, which employs 6- and 8-F catheters, was approved by the FDA under 510(k) for use by BD (Becton, Dickinson, and Company) to remove acute emboli and clots for hemodialysis access to arteriovenous grafts and native arteriovenous fistulas. This device was introduced in 2022 and operates on a three-pronged mechanism mechanical transportation for effective clot removal through the catheter and out of the channel, continuous clot maceration to prevent clogging, and enhanced clot aspiration.

U.S. Hemodialysis Vascular Grafts Market Report Highlights:

  • As the population ages and the prevalence of conditions such as diabetes and hypertension increases, more individuals require hemodialysis, driving the market for vascular grafts.
  • The polytetrafluoroethylene raw material segment dominated the market with a share of around 45.5% in 2023 and is anticipated to witness the fastest CAGR during the forecast period. This is attributed to the benefits associated with the material such as ease of handling, durability, and resistance to infection.
  • In June 2023, Merit Medical System Inc. acquired a catheter system from Bluegrass Vascular for USD 32.5 million followed with a larger USD 100 million asset purchase from AngioDynamics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Raw Material
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Raw material outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Hemodialysis Vascular Grafts Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. U.S. Hemodialysis Vascular Grafts Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Hemodialysis Vascular Grafts Market: Raw Material Estimates & Trend Analysis

  • 4.1. Raw Material Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Hemodialysis Vascular Grafts Market by Raw Material Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Polyester
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Polytetrafluoroethylene
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Polyurethane
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Biological Materials
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.4.2. Human Saphenous & Umbilical Veins
      • 4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.4.3. Tissue Engineered Materials
      • 4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Hemodialysis Vascular Grafts Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. U.S. Hemodialysis Vascular Grafts Market by Region Outlook
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
    • 5.3.1. West
      • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Midwest
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Northeast
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Southwest
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Southeast
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company heat map analysis, 2023
  • 6.4. Company Profiles
    • 6.4.1. Getinge
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Medtronic
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. W. L. Gore & Associates
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. LeMaitre
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. CryoLife
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Merit Medical Systems
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. C.R. Bard, Inc.
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Vascudyne, Inc.
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. hemodialysis vascular grafts market, by raw material, 2018 - 2030 (USD Million)
  • Table 3 U.S. hemodialysis vascular grafts market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. hemodialysis vascular grafts market: Market outlook
  • Fig. 9 U.S. hemodialysis vascular grafts competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. hemodialysis vascular grafts market driver impact
  • Fig. 14 U.S. hemodialysis vascular grafts market restraint impact
  • Fig. 15 U.S. hemodialysis vascular grafts market: Raw material movement analysis
  • Fig. 16 U.S. hemodialysis vascular grafts market: Raw material outlook and key takeaways
  • Fig. 17 Polyester market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Polytetrafluoroethylene market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Polyurethane market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Biological materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Human saphenous & umbilical veins market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 22 Tissue engineered materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. hemodialysis vascular grafts market: Regional movement analysis
  • Fig. 24 U.S. hemodialysis vascular grafts market: Regional outlook and key takeaways
  • Fig. 25 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)